Ahmed Y Aldryhim

Ahmed Y Aldryhim

Auto-generated profile, based on publicly available information

Ahmed Y Aldryhim

A Department of Clinical Pharmacy, College of Pharmacy, King Saud University , Riyadh , Saudi Arabia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
AAAhmed Y Aldryhim
Ahmed Y Aldryhim
AAAbdulrahman Alomair
Abdulrahman Alomair
MAMeshari Alqhtani
Meshari Alqhtani
MMMansour A. Mahmoud
Mansour A. Mahmoud
TAThamir M Alshammari
Thamir M Alshammari
TATariq Alhawassi
Tariq Alhawassi
Objectives: Adverse drug reactions (ADRs) are a pervasive global problem and its management is integral to patient safety and healthcare quality. Pharmacists play a pivotal role in monitoring and reporting ADRs, which has a direct impact on patient care. The aim of this study was to identify potential factors that facilitate pharmacists in community and hospital settings to report ADRs. Methods: A cross-sectional, online survey using a validated questionnaire was administered to pharmacists working in community and hospital pharmacies in Saudi Arabia. Results: 1,717 community and 153 hospital pharmacists participated in this study. Only 10.2% and 26.8% of community and hospital pharmacists respectively admitted ever reporting an ADR. The most reported factors that may facilitate ADRs reporting have included ongoing improvements in therapeutic knowledge about ADRs, attending educational programs with continuous medical education credits, the seriousness of the experienced ADRs and accessibility to patients’ medical profile. The impact of peers by seeing colleagues reporting ADRs and ADRs due to herbal or traditional medicine were the least important factors reported by pharmacists. Conclusion: The study identified factors that can effectively address the under-reporting of ADRs by pharmacists. A multi-stakeholder, multi-pronged approach of ADR reporting is needed to develop greater awareness of this issue among pharmacists.